Cleared Traditional

K222919 - GORE® ENFORM Biomaterial (FDA 510(k) Clearance)

Dec 2022
Decision
84d
Days
Class 2
Risk

K222919 is an FDA 510(k) clearance for the GORE® ENFORM Biomaterial. This device is classified as a Mesh, Surgical, Absorbable, Plastic And Reconstructive Surgery (Class II - Special Controls, product code OXF).

Submitted by W. L. Gore and Associates, Inc. (Elkton, US). The FDA issued a Cleared decision on December 19, 2022, 84 days after receiving the submission on September 26, 2022.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 878.3300. For Reinforcement Of Soft Tissue Where Weakness Exists In Plastic And Reconstructive Surgery..

Submission Details

510(k) Number K222919 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 26, 2022
Decision Date December 19, 2022
Days to Decision 84 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code OXF - Mesh, Surgical, Absorbable, Plastic And Reconstructive Surgery
Device Class Class II - Special Controls
CFR Regulation 21 CFR 878.3300
Definition For Reinforcement Of Soft Tissue Where Weakness Exists In Plastic And Reconstructive Surgery.